Brian Park, PharmD, Author at Medical Bag

Brian Park, PharmD

All articles by Brian Park, PharmD

Symdeko Approved to Treat Younger Cystic Fibrosis Patients

The Food and Drug Administration (FDA) has approved Symdeko (tezacaftor/ivacaftor and ivacaftor; Vertex Pharmaceuticals) for the treatment of patients aged ≥6 years with cystic fibrosis (CF) who are homozygous for the F508del mutation or who have at least 1 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that is responsive to tezacaftor/ivacaftor. Previously,…

Next post in Uncategorized